TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Q-linea AB ( (SE:QLINEA) ) is now available.
Q-linea AB has announced a reorganization and changes in its executive leadership team, aiming to enhance its commercial focus and operational efficiency. The restructuring includes a reduction of 16 employees in Sweden, with no impact on operations in the US and Italy, and the appointment of Ylva Molin to the Executive Management Group as Manager of Assay Development, while Jonas Melin transitions to a Senior Technical Advisor role and CFO Christer Samuelsson plans to depart.
The most recent analyst rating on (SE:QLINEA) stock is a Sell with a SEK23.50 price target. To see the full list of analyst forecasts on Q-linea AB stock, see the SE:QLINEA Stock Forecast page.
More about Q-linea AB
Q-linea is a company specializing in rapid antimicrobial susceptibility testing systems, notably the ASTar®, which aids hospitals in accelerating and simplifying workflows for treating bloodstream infections and sepsis. Headquartered in Uppsala, Sweden, with offices in Italy and the USA, Q-linea is committed to sustainable healthcare and maintaining antibiotic effectiveness.
Average Trading Volume: 13,531
Technical Sentiment Signal: Sell
Current Market Cap: SEK491.6M
Find detailed analytics on QLINEA stock on TipRanks’ Stock Analysis page.